Also trades as: THYROCARE.NS (NSE) · $vol 4M
THYROCARE.BO BSE
Thyrocare Technologies Limited
1W: -5.7%
1M: -9.3%
3M: -3.4%
YTD: +31.5%
1Y: -61.0%
3Y: -2.9%
5Y: -56.0%
₹536.00 ($5.57)
+1.65 (+0.31%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$2.2B
+13.1% ▲
5Y CAGR: +13.3%
Capital Expenditures
$209M
+53.5% ▲
5Y CAGR: -5.9%
Free Cash Flow
$2.0B
+33.5% ▲
5Y CAGR: +17.4%
Dividends Paid
$1.5B
-55.7% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$503M
+500.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.3B | $874M | $708M | $1.5B | $1.6B |
| Depreciation & Amort. | $339M | $387M | $470M | $553M | $586M |
| Stock-Based Comp. | $23M | $212M | $167M | $245M | $0 |
| Change in Working Capital | -$792M | $58M | $302M | $125M | -$85M |
| Other Non-Cash Items | $17M | $10M | $30M | -$479M | $32M |
| Operating Cash Flow | $1.1B | $1.3B | $1.7B | $1.9B | $2.2B |
| — Investing Activities — | |||||
| Capital Expenditures | -$378M | -$436M | -$616M | -$449M | -$209M |
| Acquisitions (Net) | $42M | $34M | $0 | -$112M | $54M |
| Investment Purchases | -$1.7B | -$1.9B | -$279M | $0 | -$106M |
| Investment Sales | $1.6B | $1.9B | $0 | $0 | $0 |
| Other Investing | $237M | $1M | -$18M | $36M | $0 |
| Investing Cash Flow | -$236M | -$390M | -$913M | -$525M | -$261M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$54M | -$55M | $216M | -$216M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$793M | -$794M | -$953M | -$953M | -$1.5B |
| Other Financing | -$48M | -$13M | -$111M | -$136M | -$212M |
| Financing Cash Flow | -$894M | -$862M | -$848M | -$1.3B | -$1.7B |
| Net Change in Cash | $4M | $41M | -$85M | $84M | $503M |
| Cash End of Period | $136M | $178M | $93M | $177M | $682M |
| Free Cash Flow | $756M | $857M | $1.1B | $1.5B | $2.0B |